Commentary

Commentary

Government run health care won’t improve life expectancy

Between 2021 and 2022, U.S. life expectancy jumped more than 12 months, according to new data from the Centers for Disease Control and Prevention. An American born today can now expect to live 77.5 years — up from 76.4 in 2021. Predictably, this good news didn’t register with progressives working ...
Commentary

Canadian Health Care Leaves Patients Frozen In Line

More than one-fourth of Americans receive taxpayer-funded health coverage through Medicaid or the Children’s Health Insurance Program, according to the latest federal estimates. But that “free” coverage has a significant cost. Medicaid beneficiaries must wait longer for care than those with private insurance. A study from 2021 found that Medicaid patients waited 1.3 ...
Commentary

Medicaid spending is on the rise — progressive policies are to blame

Medicaid expenditures totaled more than $805 billion in 2022, according to new data from the Centers for Medicare and Medicaid Services. That’s a 9.6% increase compared with 2021. The data are the latest indication of just how big Medicaid has become. And that’s no accident. For years, progressives have advanced policies that have nudged millions more ...
Commentary

California’s single-payer dream further away than ever

California is facing a record budget deficit next year of $68 billion. As a result, Gov. Gavin Newsom and the Democratic supermajority in the state legislature will have to scale back their progressive ambitions. Can the state really afford the looming rise in the minimum wage for healthcare workers to ...
Commentary

Biden Is Medical Innovation’s Executioner

President Joe Biden just declared war on medical science — and has undermined his “Cancer Moonshot.” That’s the only way to interpret the administration’s announcement last week arrogating the power to seize patents for medicines and other technologies developed with taxpayer funds on the grounds that they’re too expensive. The president claims ...
Commentary

Reining in the true culprit behind critical medicine shortages

Drug shortages in the United States have reached crisis levels. The Food and Drug Administration reports that nearly 140 medicines are currently in short supply. That figure includes more than a dozen cancer drugs, which has forced doctors and patients to confront the dangerous possibility of rationing. These shortages threaten ...
Agriculture

California’s Farmers Give Great Gifts to Us All – During the Holidays and All Year Long

A great many farmers and ranchers identify with Paul Harvey’s iconic poem, “So God Made a Farmer,” but this time of year, I prefer the editorial from Francis B. Church, “Yes, Virginia, there is a Santa Claus.” Whether you read Paul Harvey’s poignant poem or Francis Church’s editorial to set ...
Commentary

How 2024 Republican presidential candidates should talk about healthcare

Republican presidential candidates are once again talking about healthcare policy. At a debate earlier this month, Gov. Ron DeSantis (R-FL) discussed the need for more affordable healthcare. Vivek Ramaswamy called for a more competitive insurance marketplace. The renewed interest in healthcare among Republicans came on the heels of former President Donald Trump’s assertion that he’d seriously look at replacing ...
Commentary

Read Sally Pipes' latest at Newsmax

GOP Shouldn’t Squander Trump’s Revival of Obamacare Debate

Former President Donald Trump recently revealed he is “seriously looking at alternatives” to Obamacare. As he put it in a post on Truth Social, “[t]he cost of Obamacare is out of control, plus, it’s not good Healthcare.” Those comments should have come as good news to lawmakers looking to reduce the ...
Commentary

Giving The Gov’t Drug Patent March-In Authority Is Bad Policy

In early December, the Biden administration announced a proposal on exercising march-in rights on taxpayer-funded drugs and other inventions that allows prices to “be a factor in considering whether a drug is accessible to the public.” This is a terrible idea. As the Congressional Research Service summarized, it is an ...
Commentary

Government run health care won’t improve life expectancy

Between 2021 and 2022, U.S. life expectancy jumped more than 12 months, according to new data from the Centers for Disease Control and Prevention. An American born today can now expect to live 77.5 years — up from 76.4 in 2021. Predictably, this good news didn’t register with progressives working ...
Commentary

Canadian Health Care Leaves Patients Frozen In Line

More than one-fourth of Americans receive taxpayer-funded health coverage through Medicaid or the Children’s Health Insurance Program, according to the latest federal estimates. But that “free” coverage has a significant cost. Medicaid beneficiaries must wait longer for care than those with private insurance. A study from 2021 found that Medicaid patients waited 1.3 ...
Commentary

Medicaid spending is on the rise — progressive policies are to blame

Medicaid expenditures totaled more than $805 billion in 2022, according to new data from the Centers for Medicare and Medicaid Services. That’s a 9.6% increase compared with 2021. The data are the latest indication of just how big Medicaid has become. And that’s no accident. For years, progressives have advanced policies that have nudged millions more ...
Commentary

California’s single-payer dream further away than ever

California is facing a record budget deficit next year of $68 billion. As a result, Gov. Gavin Newsom and the Democratic supermajority in the state legislature will have to scale back their progressive ambitions. Can the state really afford the looming rise in the minimum wage for healthcare workers to ...
Commentary

Biden Is Medical Innovation’s Executioner

President Joe Biden just declared war on medical science — and has undermined his “Cancer Moonshot.” That’s the only way to interpret the administration’s announcement last week arrogating the power to seize patents for medicines and other technologies developed with taxpayer funds on the grounds that they’re too expensive. The president claims ...
Commentary

Reining in the true culprit behind critical medicine shortages

Drug shortages in the United States have reached crisis levels. The Food and Drug Administration reports that nearly 140 medicines are currently in short supply. That figure includes more than a dozen cancer drugs, which has forced doctors and patients to confront the dangerous possibility of rationing. These shortages threaten ...
Agriculture

California’s Farmers Give Great Gifts to Us All – During the Holidays and All Year Long

A great many farmers and ranchers identify with Paul Harvey’s iconic poem, “So God Made a Farmer,” but this time of year, I prefer the editorial from Francis B. Church, “Yes, Virginia, there is a Santa Claus.” Whether you read Paul Harvey’s poignant poem or Francis Church’s editorial to set ...
Commentary

How 2024 Republican presidential candidates should talk about healthcare

Republican presidential candidates are once again talking about healthcare policy. At a debate earlier this month, Gov. Ron DeSantis (R-FL) discussed the need for more affordable healthcare. Vivek Ramaswamy called for a more competitive insurance marketplace. The renewed interest in healthcare among Republicans came on the heels of former President Donald Trump’s assertion that he’d seriously look at replacing ...
Commentary

Read Sally Pipes' latest at Newsmax

GOP Shouldn’t Squander Trump’s Revival of Obamacare Debate

Former President Donald Trump recently revealed he is “seriously looking at alternatives” to Obamacare. As he put it in a post on Truth Social, “[t]he cost of Obamacare is out of control, plus, it’s not good Healthcare.” Those comments should have come as good news to lawmakers looking to reduce the ...
Commentary

Giving The Gov’t Drug Patent March-In Authority Is Bad Policy

In early December, the Biden administration announced a proposal on exercising march-in rights on taxpayer-funded drugs and other inventions that allows prices to “be a factor in considering whether a drug is accessible to the public.” This is a terrible idea. As the Congressional Research Service summarized, it is an ...
Scroll to Top